1. Market Research
  2. > Pathology
53 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Chromatography Resin Market by Type, Technique, Application, Region - Global Forecast to 2024

  • $ 4950
  • December 2019
  • 172 pages

MarketsandMarkets™ is the world' s largest revenue impact company, serving over ## customers. ##% of the top ##, ## companies globally rely on us for identifying new high growth and niche revenue opportunities.

  • Lymphoma
  • Pharmaceutical
  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Repligen Corporation

Global CT Scanner Market - Opportunities and Forecast

  • $ 2400
  • August 2019
  • 296 pages

AN INCREASED PREVALENCE OF MALIGNANT LYMPHOMA AND GASTRIC CANCER HAS BEEN OBSERVED IN LARGE COHORTS OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVID), COUPLED WITH ITALIAN HOSPITALS ASKING FOR SCANNING A LARGER PROPORTION OF PATIENTS, ACCORDING TO A ITALIAN SURVEY, ##% OF THE HOSPITA

  • CT Scan
  • Diagnostic Imaging
  • Lymphoma
  • Market Size
  • GE Healthcare Limited

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

  • $ 1995
  • November 2019
  • 144 pages

GSK discontinued the global development of GSK-## in Phase I development for relapsed or refractory small-cell lung cancer, and GSK-## in Phase I development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumors, and refractory multiple myeloma.

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Philippines
  • GE Healthcare Limited

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland

  • $ 1995
  • April 2020
  • 162 pages

R& D Capabilities: Product Discontinuations: Weakness GSK discontinued the global development of GSK-##, which was in Phase I clinical development for relapsed or refractory small-cell lung cancer; and GSK- ##, which was in Phase I trials for follicular lymphoma, diffuse large

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Poland
  • GE Healthcare Limited

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

  • $ 1995
  • August 2019
  • 140 pages

GSK discontinued the global development of GSK-## in Phase I development for relapsed or refractory small-cell lung cancer, and GSK-## in Phase I stage of development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumors, and refractory multiple myeloma.

  • Lymphoma
  • Medical Device
  • Pharmaceutical
  • Saudi Arabia
  • GE Healthcare Limited

Nuclear Medicine/Radiopharmaceutical Global Market – Forecast To 2024

  • $ 4950
  • July 2018
  • 576 pages

Y- ## are used to diagnose tumor and Ga-## is used to diagnose malignant lymphomas such as Hodgkin and non-Hodgkin lymphoma.

  • Lymphoma
  • Nuclear Power
  • World
  • Market Size
  • GE Healthcare Limited

Nanotechnology in Medicine - Thematic Research

  • $ 1950
  • June 2020
  • 28 pages

Nanotechnology in Medicine Thematic Research: Medical Nanotechnology in Medicine is on the Rise A persistent problem in medicine is the ability to specifically target diseased cells and tissues.

  • Lymphoma
  • Pharmaceutical
  • GE Healthcare Limited
  • Janssen Biotech, Inc.
  • Takeda Pharmaceutical Company Limited

Global DNA Probe-based Diagnostic Market 2017-2021

  • $ 2500
  • November 2017
  • 85 pages

For instance, the knowledge of association of Epstein- Barr virus with lymphoma and the differentiation between low-risk genotypes of a human papilloma virus from high-risk genotypes (HPV ## or ##) related to cervical carcinoma has been possible with the availability of specific DNA probes.

  • Diagnostics
  • DNA
  • Lymphoma
  • Abbott Laboratories, Inc.
  • GE Healthcare Limited

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018

  • $ 2995
  • March 2018
  • 104 pages

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 Summary Artificial intelligence (AI) is defined as the theoretical and practical application ...

  • Advanced IT
  • Artificial Intelligence
  • Healthcare
  • Pharmaceutical
  • GE Healthcare Limited

Global Nuclear Imaging Market 2017-2021

  • $ 2500
  • August 2017
  • 117 pages

Major applications in oncology are lung cancer, lymphoma, and breast cancer.

  • Lymphoma
  • Nuclear Imaging Equipment
  • Digirad Corporation
  • GE Healthcare Limited
  • Koninklijke Philips N.V.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea

  • $ 1995
  • July 2018
  • 144 pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory ...

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • South Korea
  • GE Healthcare Limited

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Sweden

  • $ 1995
  • February 2018
  • 133 pages

Lymphoma Coalition Organization.

  • Lymphoma
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • GE Healthcare Limited

Global Hybrid Imaging Market 2017-2021

  • $ 2500
  • February 2017
  • 91 pages

PET/ MRI is also used in the detection of lymphomas and lung nodules and is considered more active as compared to PET-CT.

  • CT Scan
  • Diagnostic Imaging
  • Healthcare
  • Lymphoma
  • GE Healthcare Limited

Cancer Immunotherapy Artificial Intelligence: Market Shares, Strategies, and Forecasts, 2017 to 2023

  • $ 2400
  • October 2017
  • 124 pages

Applications are for Lung, Melanoma, Leukemia, Lymphoma cancers.

  • Artificial Intelligence
  • Cancer
  • Healthcare
  • Lymphoma
  • GE Healthcare Limited

Global Toxicology Testing Market 2017-2021

  • $ 2500
  • October 2017
  • 79 pages

It offers products such as Ames II assay and Mouse Lymphoma assay.

  • Lymphoma
  • Pharmaceutical
  • Agilent Technologies, Inc.
  • GE Healthcare Limited
  • Thermo Fisher Scientific, Inc.

North American Nuclear Medicine/Radiopharmaceuticals Market by Type, Application - Forecasts to 2024

  • $ 4950
  • January 2020
  • 156 pages

The emergence of RIT has paved the way for exploring nuclear medicine for treating lymphoma.

  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States
  • GE Healthcare Limited

Nuclear Imaging Equipment Market by Product, Hybrid PET, Planar Scintigraphy, Application, End user - Global Forecasts to 2021

  • $ 4950
  • January 2017
  • 169 pages

PET-CT scanning is widely accepted as a mainstream diagnostic test for various diseases such as lung cancer, lymphomas, and colorectal carcinoma.

  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States
  • GE Healthcare Limited

Nuclear Medicine/Radiopharmaceuticals Market by Type, Application - Global Forecast to 2024

  • $ 4950
  • January 2020
  • 231 pages

THE EMERGENCE OF RIT HAS PAVED THE WAY FOR EXPLORING NUCLEAR MEDICINE FOR TREATING LYMPHOMA.

  • Lymphoma
  • Nuclear Imaging Equipment
  • North America
  • United States
  • GE Healthcare Limited

Global Nuclear Medicine Market 2016-2020

  • $ 2500
  • July 2016
  • 73 pages

Major applications in oncology involve the diagnosis of diseases such as lung cancer, lymphoma, and breast cancer.

  • CT Scan
  • Lymphoma
  • Cardinal Health, Inc.
  • Digirad Corporation
  • GE Healthcare Limited

United Kingdom Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 4995
  • February 2017
  • 42 pages

The abstracts are available on the AACR website. ##. ## GOVERNMENT AND PUBLIC INTEREST Combinations containing the aza-anthracenedione pixantrone show preclinical activity in diffuse large B-cell lymphoma (DLBCL) First Author: Chiara Tarantelli, Ph. D., IOR Institute of Oncology Research, Belli

  • CT Scan
  • Lymphoma
  • United Kingdom
  • GE Healthcare Limited
  • Toshiba Corporation
View report >

Global Gene Therapy Industry

  • January 2017
  • 120 pages

BCL- B-cell lymphoma; DLBCL- Diffuse Large B-cell lymphoma; MM= Multiple Myeloma; ALL= Acute lymphoblastic leukaemia; NHL= Non-Hodgkin lymphoma.

  • Gene Therapy
  • Lymphoma
  • Regenerative Medicine
  • Therapy
  • GE Healthcare Limited

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on